Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 22, 2016
Natus Medical Incorporated
(Exact name of registrant as specified in its charter)
|
| | | | |
Delaware | | 000-33001 | | 77-0154833 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
6701 Koll Center Parkway Suite 120 Pleasanton, CA 94566
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (925) 223-6700
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
| |
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
| |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
| |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
| |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
| |
ITEM 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On September 22, 2016, Natus Medical Incorporated (the "Company") issued a press release announcing the appointment of Barbara R. Paul, M.D. as a member of its Board of Directors.
As a non-employee director, Dr. Paul's compensation consists of a grant of 3,360 Restricted Stock Units per the Company's 2011 Stock Award Plan. The award will vest on September 21, 2017. Dr. Paul will also receive cash compensation of $45,000 pursuant to the Company's board compensation plan.
|
| |
Item 9.01. | Financial Statements and Exhibits |
(d) Exhibits.
|
| | |
Exhibit No. | | Description |
99.1 | | Press release dated September 22, 2016 announcing the appointment of Barbara R. Paul, M.D. as a member of the Board of Directors. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | | | | | |
| | | | | | |
| | | | | | NATUS MEDICAL INCORPORATED |
| | | |
Date: September 22, 2016 | | | | By: | | /s/ Jonathan A. Kennedy |
| | | | | | Jonathan A. Kennedy |
| | | | | | Senior Vice President Finance & Chief Financial Officer |
Exhibit Index
|
| | |
Exhibit No. | | Description |
99.1 | | Press release dated September 22, 2016 announcing the appointment of Barbara R. Paul, M.D. as a member of the Board of Directors. |